Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo.
Drug Des Devel Ther. 2020 Oct 9;14:4189-4203. doi: 10.2147/DDDT.S275128. eCollection 2020.
Drug Des Devel Ther. 2020.
PMID: 33116407
Free PMC article.